2018-2023 Global Immuno-oncology Drugs Consumption Market Report

Publisher Name :
Date: 16-Aug-2018
No. of pages: 184

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Immuno-oncology Drugs market for 2018-2023.

Over the next five years, LPI(LP Information) projects that Immuno-oncology Drugs will register a 14.2% CAGR in terms of revenue, reach US$ 109200 million by 2023, from US$ 49200 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Immune Checkpoint Inhibitors

- Monoclonal Antibodies

- Cytokine-Based Immunotherapy

- Cancer Vaccines

- CAR-T Cell Therapy

Segmentation by application:

- Hospitals

- Pharmacies

- Online Pharmacies

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Amgen, Inc

- AstraZeneca, Plc

- Bristol-Myers Squibb

- Celgene Corporation

- Eli Lilly and Company

- Merck & Co.

- Hoffmann-La Roche AG

- Johnson & Johnson

- Novartis International AG

- AbbVie, Inc.

- Pfizer Inc.

- Sanofi S.A.

- EMD Serono, Inc.

- Gilead Sciences Inc.

- Prometheus Therapeutics & Diagnostics

- Aduro BioTech

- Galena Biopharma

- Bavarian Nordic

- Celldex Therapeutics

- ImmunoCellular Therapeutics

- Incyte

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Immuno-oncology Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Immuno-oncology Drugs market by identifying its various subsegments.

- Focuses on the key global Immuno-oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Immuno-oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Immuno-oncology Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Immuno-oncology Drugs Consumption Market Report

Table of Contents

2018-2023 Global Immuno-oncology Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immuno-oncology Drugs Consumption 2013-2023
2.1.2 Immuno-oncology Drugs Consumption CAGR by Region
2.2 Immuno-oncology Drugs Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Monoclonal Antibodies
2.2.3 Cytokine-Based Immunotherapy
2.2.4 Cancer Vaccines
2.2.5 CAR-T Cell Therapy
2.3 Immuno-oncology Drugs Consumption by Type
2.3.1 Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Immuno-oncology Drugs Sale Price by Type (2013-2018)
2.4 Immuno-oncology Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacies
2.4.3 Online Pharmacies
2.5 Immuno-oncology Drugs Consumption by Application
2.5.1 Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Immuno-oncology Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Immuno-oncology Drugs Sale Price by Application (2013-2018)

3 Global Immuno-oncology Drugs by Players
3.1 Global Immuno-oncology Drugs Sales Market Share by Players
3.1.1 Global Immuno-oncology Drugs Sales by Players (2016-2018)
3.1.2 Global Immuno-oncology Drugs Sales Market Share by Players (2016-2018)
3.2 Global Immuno-oncology Drugs Revenue Market Share by Players
3.2.1 Global Immuno-oncology Drugs Revenue by Players (2016-2018)
3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Immuno-oncology Drugs Sale Price by Players
3.4 Global Immuno-oncology Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Immuno-oncology Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Immuno-oncology Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Immuno-oncology Drugs by Regions
4.1 Immuno-oncology Drugs by Regions
4.1.1 Global Immuno-oncology Drugs Consumption by Regions
4.1.2 Global Immuno-oncology Drugs Value by Regions
4.2 Americas Immuno-oncology Drugs Consumption Growth
4.3 APAC Immuno-oncology Drugs Consumption Growth
4.4 Europe Immuno-oncology Drugs Consumption Growth
4.5 Middle East & Africa Immuno-oncology Drugs Consumption Growth

5 Americas
5.1 Americas Immuno-oncology Drugs Consumption by Countries
5.1.1 Americas Immuno-oncology Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Immuno-oncology Drugs Value by Countries (2013-2018)
5.2 Americas Immuno-oncology Drugs Consumption by Type
5.3 Americas Immuno-oncology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Immuno-oncology Drugs Consumption by Countries
6.1.1 APAC Immuno-oncology Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Immuno-oncology Drugs Value by Countries (2013-2018)
6.2 APAC Immuno-oncology Drugs Consumption by Type
6.3 APAC Immuno-oncology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Immuno-oncology Drugs by Countries
7.1.1 Europe Immuno-oncology Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Immuno-oncology Drugs Value by Countries (2013-2018)
7.2 Europe Immuno-oncology Drugs Consumption by Type
7.3 Europe Immuno-oncology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Immuno-oncology Drugs by Countries
8.1.1 Middle East & Africa Immuno-oncology Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Immuno-oncology Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Immuno-oncology Drugs Consumption by Type
8.3 Middle East & Africa Immuno-oncology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Immuno-oncology Drugs Distributors
10.3 Immuno-oncology Drugs Customer

11 Global Immuno-oncology Drugs Market Forecast
11.1 Global Immuno-oncology Drugs Consumption Forecast (2018-2023)
11.2 Global Immuno-oncology Drugs Forecast by Regions
11.2.1 Global Immuno-oncology Drugs Forecast by Regions (2018-2023)
11.2.2 Global Immuno-oncology Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Immuno-oncology Drugs Forecast by Type
11.8 Global Immuno-oncology Drugs Forecast by Application

12 Key Players Analysis
12.1 Amgen, Inc
12.1.1 Company Details
12.1.2 Immuno-oncology Drugs Product Offered
12.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Amgen, Inc News
12.2 AstraZeneca, Plc
12.2.1 Company Details
12.2.2 Immuno-oncology Drugs Product Offered
12.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 AstraZeneca, Plc News
12.3 Bristol-Myers Squibb
12.3.1 Company Details
12.3.2 Immuno-oncology Drugs Product Offered
12.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Bristol-Myers Squibb News
12.4 Celgene Corporation
12.4.1 Company Details
12.4.2 Immuno-oncology Drugs Product Offered
12.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Celgene Corporation News
12.5 Eli Lilly and Company
12.5.1 Company Details
12.5.2 Immuno-oncology Drugs Product Offered
12.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Eli Lilly and Company News
12.6 Merck & Co.
12.6.1 Company Details
12.6.2 Immuno-oncology Drugs Product Offered
12.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Merck & Co. News
12.7 Hoffmann-La Roche AG
12.7.1 Company Details
12.7.2 Immuno-oncology Drugs Product Offered
12.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Hoffmann-La Roche AG News
12.8 Johnson & Johnson
12.8.1 Company Details
12.8.2 Immuno-oncology Drugs Product Offered
12.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Johnson & Johnson News
12.9 Novartis International AG
12.9.1 Company Details
12.9.2 Immuno-oncology Drugs Product Offered
12.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Novartis International AG News
12.10 AbbVie, Inc.
12.10.1 Company Details
12.10.2 Immuno-oncology Drugs Product Offered
12.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 AbbVie, Inc. News
12.11 Pfizer Inc.
12.12 Sanofi S.A.
12.13 EMD Serono, Inc.
12.14 Gilead Sciences Inc.
12.15 Prometheus Therapeutics & Diagnostics
12.16 Aduro BioTech
12.17 Galena Biopharma
12.18 Bavarian Nordic
12.19 Celldex Therapeutics
12.20 ImmunoCellular Therapeutics
12.21 Incyte

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Immuno-oncology Drugs
Table Product Specifications of Immuno-oncology Drugs
Figure Immuno-oncology Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Immuno-oncology Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Immuno-oncology Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Immuno-oncology Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Immune Checkpoint Inhibitors
Table Major Players of Immune Checkpoint Inhibitors
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Product Picture of Cytokine-Based Immunotherapy
Table Major Players of Cytokine-Based Immunotherapy
Figure Product Picture of Cancer Vaccines
Table Major Players of Cancer Vaccines
Figure Product Picture of CAR-T Cell Therapy
Table Major Players of CAR-T Cell Therapy
Table Global Consumption Sales by Type (2013-2018)
Table Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Type (2013-2018) ($ million)
Table Global Immuno-oncology Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Immuno-oncology Drugs Value Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Sale Price by Type (2013-2018)
Figure Immuno-oncology Drugs Consumed in Hospitals
Figure Global Immuno-oncology Drugs Market: Hospitals (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Immuno-oncology Drugs Consumed in Pharmacies
Figure Global Immuno-oncology Drugs Market: Pharmacies (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Pharmacies (2013-2018) ($ Millions)
Figure Global Pharmacies YoY Growth ($ Millions)
Figure Immuno-oncology Drugs Consumed in Online Pharmacies
Figure Global Immuno-oncology Drugs Market: Online Pharmacies (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Online Pharmacies (2013-2018) ($ Millions)
Figure Global Online Pharmacies YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Value by Application (2013-2018)
Table Global Immuno-oncology Drugs Value Market Share by Application (2013-2018)
Figure Global Immuno-oncology Drugs Value Market Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Sale Price by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales by Players (2016-2018) (K Units)
Table Global Immuno-oncology Drugs Sales Market Share by Players (2016-2018)
Figure Global Immuno-oncology Drugs Sales Market Share by Players in 2016
Figure Global Immuno-oncology Drugs Sales Market Share by Players in 2017
Table Global Immuno-oncology Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Immuno-oncology Drugs Revenue Market Share by Players (2016-2018)
Figure Global Immuno-oncology Drugs Revenue Market Share by Players in 2016
Figure Global Immuno-oncology Drugs Revenue Market Share by Players in 2017
Table Global Immuno-oncology Drugs Sale Price by Players (2016-2018)
Figure Global Immuno-oncology Drugs Sale Price by Players in 2017
Table Global Immuno-oncology Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Immuno-oncology Drugs Products Offered
Table Immuno-oncology Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Immuno-oncology Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share by Regions 2013-2018
Figure Global Immuno-oncology Drugs Consumption Market Share by Regions 2013-2018
Table Global Immuno-oncology Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share by Regions 2013-2018
Figure Global Immuno-oncology Drugs Value Market Share by Regions 2013-2018
Figure Americas Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Americas Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure APAC Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure APAC Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure Europe Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Europe Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Table Americas Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Americas Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Americas Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Americas Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure United States Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table APAC Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Drugs Value Market Share by Countries in 2017
Table APAC Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table APAC Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure China Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure China Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure India Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure India Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Europe Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Europe Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Europe Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure Germany Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure France Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure France Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure Egypt Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Immuno-oncology Drugs Distributors List
Table Immuno-oncology Drugs Customer List
Figure Global Immuno-oncology Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Immuno-oncology Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Forecast by Regions
Table Global Immuno-oncology Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Regions
Figure Americas Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Americas Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure APAC Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure APAC Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Europe Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Europe Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure United States Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure United States Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Canada Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Canada Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Mexico Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Mexico Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Brazil Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Brazil Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure China Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure China Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Japan Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Japan Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Korea Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Korea Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure India Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure India Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Australia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Australia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Germany Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Germany Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure France Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure France Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure UK Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure UK Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Italy Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Italy Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Russia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Russia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Spain Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Spain Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Egypt Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Egypt Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure South Africa Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure South Africa Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Israel Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Israel Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Turkey Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Turkey Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Table Global Immuno-oncology Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Immuno-oncology Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Application (2018-2023)
Table Amgen, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen, Inc Immuno-oncology Drugs Market Share (2016-2018)
Table AstraZeneca, Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Market Share (2016-2018)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celgene Corporation Immuno-oncology Drugs Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Market Share (2016-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co. Immuno-oncology Drugs Market Share (2016-2018)
Table Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Market Share (2016-2018)
Table Novartis International AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis International AG Immuno-oncology Drugs Market Share (2016-2018)
Table AbbVie, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Market Share (2016-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EMD Serono, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aduro BioTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galena Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Incyte Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Global White Willow Bark Extract Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 117
    White willow bark is used for the treatment of pain such as lower back and osteoarthritis in regions of Asia and Europe. Scope of the Report: White willow bark extract is slowly gaining popularity and is expected to show a steady increase in the revenue growth. The worldwide market for White Willow Bark Extract is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR ......
  • Global Wintergreen Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Wintergreen oil is of high importance and has a high reputation since ages as it possesses various therapeutic properties such as anti-rheumatic, anti-arthritic, antiseptic, aromatic, analgesic properties, etc. Scope of the Report: Due to change in the market trend, people are more interested in natural products which will play an important role in fueling the growth of present Wintergreen Oil Market. The worldwide market for Wintergreen Oil is expected to grow at a ......
  • Global Irritable Bowel Syndrome Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms. Scope of the Report: Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowe......
  • Global Peppermint Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Peppermint Oil is the oil that is extracted from the stem and flowers of the peppermint herb. Scope of the Report: This report focuses on the Peppermint Oil in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Peppermint Oil is expected to grow at a CAGR of roughly xx% over the next five years, wi......
  • Global Dermal Adhesives Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    A dermal adhesive (or skin glue) is a glue used to close wounds in the skin, as an alternative to sutures, staples or clips. Scope of the Report: Glued closure produces less scarring and is less prone to infection than sutured or stapled closure. There is also no residual closure to remove, so follow-up visits for removal are not required. The factor that contributes to the growth of the global Skin Glue market is the rising number of traumatic injuries. The market g......
  • Global Skin Glue Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 123
    A dermal adhesive (or skin glue) is a glue used to close wounds in the skin, as an alternative to sutures, staples or clips. Scope of the Report: Glued closure produces less scarring and is less prone to infection than sutured or stapled closure. There is also no residual closure to remove, so follow-up visits for removal are not required. The factor that contributes to the growth of the global Skin Glue market is the rising number of traumatic injuries. The market g......
  • Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help......
  • Global Alpha Glucosidase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day. ......
  • Global Cancer Pain Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response. Scope of the Report: The report, states that opioids will continue to dominate as a breakthrough cancer pain treatment, mostly due to available generics and physician familiarity. The worldwide market for Cancer Pain is expected to grow at a CAGR of roughly xx......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs